Survival rates can range anywhere from 4 - 6 months or as long as a year with
additional chemotherapy treatments.
Not exact matches
After the patient has returned home from the hospital, the next stage of
treatment is consolidation, in which patients receive several
additional rounds of
chemotherapy to build upon the effects of induction.
So with an appropriate test, patients could avoid getting
additional radiation or
chemotherapy treatment they may not need, Dr. Shay said.
«We found very high response rates to this
treatment combination, which has the added benefit of having a much reduced risk of long - term organ damage compared to the highly toxic
chemotherapy agents typically used for patients with relapsed Hodgkin lymphoma,» says Dr. Kelly, who is Program Director of the Pediatric Hematology / Oncology Service Line at the Women & Children's Hospital of Buffalo and holds an
additional faculty appointment with the University at Buffalo.
Fajkovic: «Patients could then conceivably be offered
additional supportive
treatment straightaway, for example, radiotherapy or
chemotherapy — rather than waiting to see.»
This translated into a median overall survival of 57.6 months for men who received early
chemotherapy compared with 44 months in the group given ADT as the only initial
treatment — more than a year of
additional life.
Additional treatment, such as
chemotherapy, will depend on the biopsy results.
Additional staging tests confirmed the diagnosis of B - cell lymphoma so
treatment with a multidrug
chemotherapy protocol was initiated.